Antibody-fusion protein conjugates

CO20260002199A2Pending Publication Date: 2026-07-10SIXPEAKS BIO AG
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CO · CO
Patent Type
Applications
Current Assignee / Owner
SIXPEAKS BIO AG
Filing Date
2026-02-24
Publication Date
2026-07-10
Patent Text Reader

Abstract

The present invention relates to immunoglobulins, such as immunoconjugates, comprising an ActRII receptor antibody and a GLP-1 agonist molecule, such as a GLP-1 agonist peptide. Such constructs are useful in the treatment of numerous diseases and disorders, including metabolic disorders such as obesity, diabetes, and others.
Need to check novelty before this filing date? Find Prior Art